Embedding clinical interventions into observational studies

被引:12
作者
Newman, Anne B. [1 ]
Aviles-Santa, M. Larissa [2 ]
Anderson, Garnet [3 ]
Heiss, Gerardo [4 ]
Howard, Wm. James [5 ]
Krucoff, Mitchell [6 ,7 ]
Kuller, Lewis H. [8 ]
Lewis, Cora E. [9 ]
Robinson, Jennifer G. [10 ]
Taylor, Herman [11 ]
Trevino, Roberto P. [12 ]
Weintraub, William [13 ]
机构
[1] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA
[2] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA
[3] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[4] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA
[5] Medstar Washington Hosp Ctr, Medstar Hlth Res Inst, Dept Internal Med, Washington, DC 20010 USA
[6] Duke Univ, Dept Med, Med Ctr, Durham, NC 27705 USA
[7] Duke Univ, Dept Cardiol, Med Ctr, Durham, NC 27705 USA
[8] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15213 USA
[9] Univ Alabama Birmingham, Sch Med, Div Prevent Med, Birmingham, AL 35205 USA
[10] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA
[11] Univ Mississippi, Med Ctr, Jackson Heart Study, Jackson, MS 39216 USA
[12] Social & Hlth Res Ctr, San Antonio, TX 78210 USA
[13] Christiana Care Hlth Syst, Ctr Heart & Vasc Hlth, Newark, DE 19713 USA
关键词
Epidemiology; Observational study; Cohort; Clinical trial; Hybrid design; POSTMENOPAUSAL HORMONE-THERAPY; ESTROGEN PLUS PROGESTIN; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; GINKGO EVALUATION; BLOOD-PRESSURE; BREAST-CANCER; LOWER TARGETS; RECRUITMENT; WOMEN;
D O I
10.1016/j.cct.2015.11.017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Novel approaches to observational studies and clinical trials could improve the cost-effectiveness and speed of translation of research. Hybrid designs that combine elements of clinical trials with observational registries or cohort studies should be considered as part of a long-term strategy to transform clinical trials and epidemiology, adapting to the opportunities of big data and the challenges of constrained budgets. Important considerations include study aims, timing, breadth and depth of the existing infrastructure that can be leveraged, participant burden, likely participation rate and available sample size in the cohort, required sample size for the trial, and investigator expertise. Community engagement and stakeholder (including study participants) support are essential for these efforts to succeed. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 50 条
  • [31] Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
    Miravitlles, Marc
    Price, David
    Rabe, Klaus F.
    Schmidt, Hendrik
    Metzdorf, Norbert
    Celli, Bartolome
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 549 - 564
  • [32] Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results
    Mahinrad, Simin
    Sorond, Farzaneh A.
    Gorelick, Philip B.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (04) : 1429 - 1449
  • [33] Principal types of observational epidemiological studies
    Bousquet, PJ
    Bousquet, J
    Daures, JP
    Demoly, P
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2004, 44 (06): : 509 - 515
  • [34] Air pollution and metabolic syndrome risk: Evidence from nine observational studies
    Zang, Si-Tian
    Luan, Jie
    Li, Ling
    Wu, Qi-Jun
    Chang, Qing
    Dai, Hui-Xu
    Zhao, Yu-Hong
    ENVIRONMENTAL RESEARCH, 2021, 202
  • [35] For debate: Should observational clinical studies require ethics committee approval?
    Orchard, John
    JOURNAL OF SCIENCE AND MEDICINE IN SPORT, 2008, 11 (03) : 239 - 242
  • [36] The role of observational studies in optimizing the clinical management of chronic myeloid leukemia
    Mauro, Michael J.
    Davis, Catherine
    Zyczynski, Teresa
    Khoury, H. Jean
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (01) : 3 - 14
  • [37] Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
    M J Sorich
    M Coory
    The Pharmacogenomics Journal, 2014, 14 : 1 - 5
  • [38] Understanding Hispanic/Latino Participation in Clinical Trials and Observational Studies, and Strategies to Increase Participation: A Targeted Literature Review
    Dreyfus, Brian
    Kuri, Lorena
    Ferri, Mauricio
    Doykos, Patricia
    Fazeli, Mir Sohail
    Hofer, Kimberly
    Andonova, Antonia
    Ferri, Leticia
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2023, 34 (01) : 399 - 424
  • [39] European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
    Mosca, M.
    Tani, C.
    Aringer, M.
    Bombardieri, S.
    Boumpas, D.
    Brey, R.
    Cervera, R.
    Doria, A.
    Jayne, D.
    Khamashta, M. A.
    Kuhn, A.
    Gordon, C.
    Petri, M.
    Rekvig, O. P.
    Schneider, M.
    Sherer, Y.
    Shoenfeld, Y.
    Smolen, J. S.
    Talarico, R.
    Tincani, A.
    van Vollenhoven, R. F.
    Ward, M. M.
    Werth, V. P.
    Carmona, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1269 - 1274
  • [40] Current therapeutic interventions in the glycation pathway: evidence from clinical studies
    Engelen, L.
    Stehouwer, C. D. A.
    Schalkwijk, C. G.
    DIABETES OBESITY & METABOLISM, 2013, 15 (08) : 677 - 689